We use privacy-friendly analytics. Read our privacy policy.

Compound Profile

Acetyl L Carnitine

Mental fatigue; mitochondrial energy context; safety screen: seizure disorder; warfarin; hypothyroid medication review.

Use extra caution — Review with seizure history, warfarin, or thyroid medication plans. Details

Last reviewed: Report a correctionProfile-wide ·D Preliminary
Acetyl L Carnitine monograph visual
Generated profile category visual

At a glance

From this profile's structured data
Evidence
Grade D
Safety
Review with seizure history, warfarin, or thyroid-medication plans.
Profile context
mitochondrial metabolism, cholinergic system, acetylcholine mitochondria
Next steps

Continue reading

Quick stats

Evidence level
Preliminary evidence
Typical onset
Varies by prep
Safety rating
Use extra caution: Interaction risk
Best for
Mitochondrial Metabolism, Cholinergic System, Acetylcholine Mitochondria
Avoid / review if
Caution In Seizure Disorders.

Safety

Safety & Cautions

Review with seizure history, warfarin, or thyroid medication plans.

High caution

Caution level: High. Multiple caution categories apply, or the record uses avoid/contraindication language.

  • Interaction-AwareMedication or interaction context is explicitly noted.
  • Hormonal Activity ContextHormone-adjacent wording is present and should be interpreted carefully.
  • Anticoagulant CautionBleeding or anticoagulant-adjacent caution language is present.

Evidence Summary

Profile-wide ·D Preliminary

Evidence lens

Early signal that needs stronger human replication before practical claims.

PreliminaryPreliminary evidence

Human clinical evidence: Present in source signals

Mechanistic / preclinical: Mechanism mapped — Inflammatory Signaling Modulation · Mitochondrial Support · Metabolic Regulation

Research maturity: Preliminary research — Early findings are not treated as established consumer benefit.

Safety boundary: Safety note available — Review with seizure history, warfarin, or thyroid medication plans.

Evidence Strength

Confidence estimate based on the design quality and consistency of published clinical trials.

Preliminary evidence

Acetyl L Carnitine has a preliminary evidence rating.

General wellnessGeneral wellness
Citation density
0.3
Sources
1
Effects
3
Research recency
Mixed recency
Evidence Grade

Grade D: Preliminary / Theoretical Evidence

Evaluation of methodological rigor, population reach, and evidence alignment.

Design Match
Meta analysis
Risk of Bias
Low
Consistency
Not assessed
Strongest recorded design is a meta analysis, drawn from 1 recorded study, 1 in people.
How evidence grades work

Each grade reflects the strength and consistency of published human evidence — not marketing claims. Grades are based on study count, design quality, effect size, consistency, and recency.

Strong
Multiple RCTs, consistent direction, adequate effect size
Moderate
Some RCTs or consistent observational data in humans
Preliminary / Mixed
Animal or in-vitro only, or conflicting human data
Traditional / Theoretical
Traditional use only; no controlled human trials
Clinical Study Summaries (1)1 human evidence source · 0 human trials · Participant totals not consistently reported · Consistency not yet classifiable

What the evidence actually shows

This table contains 1 structured source, including 1 human evidence source; 0 are human trials.

StudyDesignNDoseDurationPopulationOutcomeResult & magnitudeSource

Current Evidence of Acetyl-L-Carnitine Use in Mood Disorders-: A Systematic Review and Meta-Analysis

Background
Meta-analysis

Statistically combines results from multiple eligible studies; confidence still depends on the quality, consistency, and directness of those studies.

—————Primary RCT meta-analysis favored acetyl-L-carnitine (SMD -1.20, 95% CI -2.12 to -0.29; p=0.01).PubMed →

How Acetyl L Carnitine Works

Simplified mechanism pathway based on preclinical and pharmacological evidence. Does not confirm clinical efficacy.

Mechanism Pathway — How Acetyl L Carnitine Works

How Acetyl L Carnitine WorksAcetyl L Carnitine acts on biological target pathways via anti inflammatory, leading to mitochondrial metabolism.Acetyl L CarnitineBiological TargetBiological pathwayAnti InflammatoryMitochondrial MetabolismObservable outcomeMitochondrialBiogenesis
CompoundTarget / ReceptorMechanismEffect / Outcome

Dosing

Common form
softgel or liquid oil
No standardized dose
Our source data records the usual product form for this ingredient but no studied dose. Preparations differ widely, so follow the standardization on the product you actually have and speak to a clinician before starting.
Mechanisms & biological pathways

Preclinical mechanism details from scientific profiles; these represent plausible pathways but do not guarantee clinical efficacy in humans.

  • Inflammatory Signaling Modulation
  • Mitochondrial Support
  • Metabolic Regulation
  • Neurotransmitter Modulation
  • Hormonal Signaling Context
  • Neuroprotective Activity

Continue exploring

Related research paths

Compare & Sourcing

Compare side-by-side tradeoffs or verify active marker guidelines.

Free safety checklist

Get the Acetyl L Carnitine evidence notes

Occasional research updates, safety context, and product-quality checks for supplement decisions.

We use your email to send the checklist and occasional evidence-first supplement updates. Unsubscribe anytime. Privacy policy.

Safety first · Harm reduction

This information is educational and not medical advice. Start low, avoid risky combinations, and consult a licensed clinician before making health decisions—especially if you use medications, have diagnosed conditions, or are pregnant/breastfeeding.

Learn how we evaluate confidence, safety, and intensity on the methodology page.

Editorial Review

Checked against primary sources, cited evidence, and contraindication language before publication. Evidence claims, safety language, and affiliate modules are reviewed independently. Not personal medical advice.

Editorial Standards →

Help improve this profile

Was this useful for your research?

These controls record only the page and the structured choice you make when analytics consent is enabled. Please don’t include personal medical information in research requests.

Was this evidence summary clear?

Did you find what you were researching?